Cargando…

A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain

A bovine herpesvirus 1 (BoHV-1) defective in glycoprotein E (gE) was constructed from a Brazilian genital BoHV-1 isolate, by replacing the full gE coding region with the green fluorescent protein (GFP) gene for selection. Upon co-transfection of MDBK cells with genomic viral DNA plus the GFP-bearing...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, M., Brum, M.C.S., Anziliero, D., Weiblen, R., Flores, E.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568813/
https://www.ncbi.nlm.nih.gov/pubmed/26200229
http://dx.doi.org/10.1590/1414-431X20154243
_version_ 1782389952176193536
author Weiss, M.
Brum, M.C.S.
Anziliero, D.
Weiblen, R.
Flores, E.F.
author_facet Weiss, M.
Brum, M.C.S.
Anziliero, D.
Weiblen, R.
Flores, E.F.
author_sort Weiss, M.
collection PubMed
description A bovine herpesvirus 1 (BoHV-1) defective in glycoprotein E (gE) was constructed from a Brazilian genital BoHV-1 isolate, by replacing the full gE coding region with the green fluorescent protein (GFP) gene for selection. Upon co-transfection of MDBK cells with genomic viral DNA plus the GFP-bearing gE-deletion plasmid, three fluorescent recombinant clones were obtained out of approximately 5000 viral plaques. Deletion of the gE gene and the presence of the GFP marker in the genome of recombinant viruses were confirmed by PCR. Despite forming smaller plaques, the BoHV-1△gE recombinants replicated in MDBK cells with similar kinetics and to similar titers to that of the parental virus (SV56/90), demonstrating that the gE deletion had no deleterious effects on replication efficacy in vitro. Thirteen calves inoculated intramuscularly with BoHV-1△gE developed virus neutralizing antibodies at day 42 post-infection (titers from 2 to 16), demonstrating the ability of the recombinant to replicate and to induce a serological response in vivo. Furthermore, the serological response induced by recombinant BoHV-1△gE could be differentiated from that induced by wild-type BoHV-1 by the use of an anti-gE antibody ELISA kit. Taken together, these results indicated the potential application of recombinant BoHV-1 △gE in vaccine formulations to prevent the losses caused by BoHV-1 infections while allowing for differentiation of vaccinated from naturally infected animals.
format Online
Article
Text
id pubmed-4568813
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Associação Brasileira de Divulgação Científica
record_format MEDLINE/PubMed
spelling pubmed-45688132015-09-29 A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain Weiss, M. Brum, M.C.S. Anziliero, D. Weiblen, R. Flores, E.F. Braz J Med Biol Res Clinical Investigation A bovine herpesvirus 1 (BoHV-1) defective in glycoprotein E (gE) was constructed from a Brazilian genital BoHV-1 isolate, by replacing the full gE coding region with the green fluorescent protein (GFP) gene for selection. Upon co-transfection of MDBK cells with genomic viral DNA plus the GFP-bearing gE-deletion plasmid, three fluorescent recombinant clones were obtained out of approximately 5000 viral plaques. Deletion of the gE gene and the presence of the GFP marker in the genome of recombinant viruses were confirmed by PCR. Despite forming smaller plaques, the BoHV-1△gE recombinants replicated in MDBK cells with similar kinetics and to similar titers to that of the parental virus (SV56/90), demonstrating that the gE deletion had no deleterious effects on replication efficacy in vitro. Thirteen calves inoculated intramuscularly with BoHV-1△gE developed virus neutralizing antibodies at day 42 post-infection (titers from 2 to 16), demonstrating the ability of the recombinant to replicate and to induce a serological response in vivo. Furthermore, the serological response induced by recombinant BoHV-1△gE could be differentiated from that induced by wild-type BoHV-1 by the use of an anti-gE antibody ELISA kit. Taken together, these results indicated the potential application of recombinant BoHV-1 △gE in vaccine formulations to prevent the losses caused by BoHV-1 infections while allowing for differentiation of vaccinated from naturally infected animals. Associação Brasileira de Divulgação Científica 2015-07-21 /pmc/articles/PMC4568813/ /pubmed/26200229 http://dx.doi.org/10.1590/1414-431X20154243 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigation
Weiss, M.
Brum, M.C.S.
Anziliero, D.
Weiblen, R.
Flores, E.F.
A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain
title A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain
title_full A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain
title_fullStr A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain
title_full_unstemmed A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain
title_short A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain
title_sort glycoprotein e gene-deleted bovine herpesvirus 1 as a candidate vaccine strain
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568813/
https://www.ncbi.nlm.nih.gov/pubmed/26200229
http://dx.doi.org/10.1590/1414-431X20154243
work_keys_str_mv AT weissm aglycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain
AT brummcs aglycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain
AT anzilierod aglycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain
AT weiblenr aglycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain
AT floresef aglycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain
AT weissm glycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain
AT brummcs glycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain
AT anzilierod glycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain
AT weiblenr glycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain
AT floresef glycoproteinegenedeletedbovineherpesvirus1asacandidatevaccinestrain